What is NDC 62756-430?

62756-430 is the product NDC for Lithium Carbonate, Lithium carbonate 300 mg/1 tablet, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.

Sun Pharmaceutical Industries, Inc., NDC labeler code 62756. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Lithium Carbonate?

61 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Lithium Carbonate NDC 62756-430 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)62756-430Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62756-0430Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62756-430-08	62756043008	100 TABLET in 1 BOTTLE (62756-430-08)Marketed from Jul 8, 2010
62756-430-18	62756043018	1000 TABLET in 1 BOTTLE (62756-430-18)Marketed from Jul 8, 2010
62756-430-83	62756043083	30 TABLET in 1 BOTTLE (62756-430-83)Marketed from Jul 8, 2010
62756-430-88	62756043088	100 TABLET in 1 BOTTLE (62756-430-88)Marketed from Jul 8, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Lithium Carbonate
Generic name (nonproprietary): lithium carbonate
Active ingredients: Lithium carbonate — 300 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Sun Pharmaceutical Industries, Inc.NDC labeler code 62756
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 091027
Marketing start: Jul 8, 2010
Listing expires: Dec 31, 2026
Identifiers: Product ID 62756-430_b0888aa2-be9d-4a45-81b2-a59493bc4892SPL ID b0888aa2-be9d-4a45-81b2-a59493bc4892SPL set ID d3284649-ed4c-4096-987b-4ac16b8278f2RxCUI 197890UNII 2BMD2GNA4VUPC 0362756430884
Pharmacologic class: Mood Stabilizer

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462756043008 followed by a unit qualifier and the quantity

Package 62756-0430-08. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 2, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

Lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: Treatment of acute manic and mixed episodes in patients 7 years and older [see Clinical Studies (14)] Maintenance treatment in patients 7 years and older [see Clinical Studies (14)] Lithium is a mood-stabilizing agent indicated as monotherapy for the treatment of bipolar I disorder: Treatment of acute manic and mixed episodes in patients 7 years and older ( 1 ) Maintenance treatment in patients 7 years and older ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 62756-430

What is NDC 62756-430?: 62756-430 is the product NDC for Lithium Carbonate, Lithium carbonate 300 mg/1 tablet, listed with the FDA by Sun Pharmaceutical Industries, Inc.. It has 4 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Lithium Carbonate.
What is the active ingredient?: Lithium carbonate.
Who is the labeler?: Sun Pharmaceutical Industries, Inc., NDC labeler code 62756. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Lithium Carbonate?: 61 other product NDCs are listed under this name. See all Lithium Carbonate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Lithium Carbonate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Lithium Carbonate	Lithium carbonate 300 mg/1	TabletOral	Hikma Pharmaceuticals USA Inc.	0054-0886	00054-0886-2500054-0886-31
Lithium Carbonate	Lithium carbonate 150 mg/1	Capsule, Gelatin coatedOral	Hikma Pharmaceuticals USA Inc.	0054-0887	00054-0887-25
Lithium Carbonate	Lithium carbonate 300 mg/1	Capsule, Gelatin coatedOral	Hikma Pharmaceuticals USA Inc.	0054-0890	00054-0890-2500054-0890-31
Lithium Carbonate	Lithium carbonate 600 mg/1	Capsule, Gelatin coatedOral	Hikma Pharmaceuticals USA Inc.	0054-0891	00054-0891-25
lithium carbonate	Lithium carbonate 150 mg/1	CapsuleOral	Coupler LLC	67046-1690	67046-1690-03
Lithium Carbonate	Lithium carbonate 450 mg/1	Tablet, Extended releaseOral	REMEDYREPACK INC.	70518-4678	70518-4678-00
Lithium Carbonate	Lithium carbonate 600 mg/1	CapsuleOral	American Health Packaging	60687-964	60687-0964-21
Lithium Carbonate	Lithium carbonate 150 mg/1	CapsuleOral	Coupler LLC	67046-0547	67046-0547-03
lithium carbonate	Lithium carbonate 150 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4627	70518-4627-00
Lithium Carbonate	Lithium carbonate 300 mg/1	Tablet, Film coated, Extended releaseOral	Coupler LLC	67046-1575	67046-1575-03

All 62 Lithium Carbonate NDCs